Retinal Neurodegeneration as a Potential Biomarker of Accelerated Aging in Schizophrenia Spectrum Disorders.
Brittany A BloseAdriann LaiChristen CrostaJudy L ThompsonSteven M SilversteinPublished in: Schizophrenia bulletin (2023)
The results suggest that retinal atrophy occurs at an increased rate in schizophrenia spectrum disorders, potentially reflecting accelerated aging inherent to these conditions, with considerable contributions from systemic medical diseases closely linked to this population.